Nuklearmedizin 2011; 50(01): N8-N11
DOI: 10.1055/s-0037-1621121
Case report
Schattauer GmbH

Third resection of pheochromocytoma aided by preoperative 123I-MIBG scintigraphy and intraoperative gamma probe measurements

Further Information

Publication History

Publication Date:
09 January 2018 (online)

 

 
  • References

  • 1 Adams S, Acker P, Lorenz M. et al. Radioisotope- guided surgery in patients with pheochromocyto- ma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumour localization with histopathologic findings. Cancer 2001; 92: 263-270.
  • 2 Brunaud L, Cormier L, Ayav A. et al. Usefulness of intraoperative 123I-MIBG during reoperation for malignant pheochromocytoma: a case report. Ann Chir 2002; 127: 225-227.
  • 3 Buhl T, Mortensen J, Kjaer A. 123I MIBG imaging and intraoperative localization of metastatic pheochromocytoma: A case report. Clin Nucl Med 2002; 27: 183-185.
  • 4 Das S, Lowe P. Malignant pheochromocytoma of the bladder. J Urol 1980; 123: 282-284.
  • 5 Frank-Raue K, Raue F, Buhr HJ. et al. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 1992; 2: 113-117.
  • 6 Havekes B, Lai EW, Corssmit EP. et al. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 2008; 52: 419-429.
  • 7 Heij HA, Rutgers EJ, de Kraker J, Vos A. Intraoperative search for neuroblastoma by MIBG and radio- guided surgery with the gamma detector. Med Pedi- atr Oncol 1997; 28: 171-174.
  • 8 Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 1994; 21: 561-581.
  • 9 Hoegerle S, Nitzsche E, Altehoefer C. et al. Pheoch- romocytomas: detection with 18F DOPA whole body PET-initial results. Radiology 2002; 222: 507-512.
  • 10 Lehnert H, Weber P, Nägele-Wöhrle B. et al. Intraoperative localization of malignant pheoch- romocytoma by 123-I-metaiodobenzylguanidine single probe measurement. Klin Wochenschr 1988; 66: 61-64.
  • 11 Luster M, Karges W, Zeich K. et al. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocy- toma. Eur J Nucl Med Mol Imaging 2010; 37: 484-493.
  • 12 Meyer-Rochow GY, Schembri GP, Benn DE. et al. Utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma. Ann Surg Oncol 2010; 17: 392-400.
  • 13 Moertel CG. An odyssey in the land of small tumours. J Clin Oncol 1987; 5: 1503-1522.
  • 14 Nunez R, Erwin WD, Wendt RE. et al. Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner. Mol Imaging Biol 2010; 12: 110-138.
  • 15 Perkins A. Peroperative nuclear medicine. Eur J Nucl Med 1993; 20: 573-575.
  • 16 Shimotake T, Tsuda T, Aoi S. et al. Iodine 123 meta- iodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B. J Pediatr Surg 2005; 40: 1643-1646.
  • 17 Sundin A, Eriksson B, Bergstrom M. et al. Demonstration of [11C]5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumours by specific positioning labeling in positron emission tomography. Nucl Med Biol 2000; 27: 33-41.
  • 18 Van Heerden JA, Roland CF, Carnery A. et al. Long term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg 1990; 14: 325-329.
  • 19 Van Luijk IF, Arndt JW, Jeurissen F, Kagie MJ. Intraoperative detection of carcinoid tumour of the ovary by gamma probe. Clin Nucl Med 2004; 29: 343-345.